Interestingly, inhibition of ACAT1, which we found markedly increased upon ORP6 knockdown, can ameliorate amyloid pathology in mice with AD (87), suggesting that restoring ORP6 expression may reverse AD-related lipid dysmetabolism. This evidence concerns the gene OSBPL6 and Alzheimer disease.